| Sridevi NS et al. |
|---|
|
Obesity and Alzheimer’s Disease: a Systematic Review // Adipositas und Alzheimer – ein systematisches Review Journal für Neurologie, Neurochirurgie und Psychiatrie 2026; 27 (4): 81-88 Volltext (PDF) Summary Keywords: Adipositas, Alzheimer-Erkrankung, Entzündung, Lebensqualität, neurodegenerativ, Stoffwechsel, Alzheimer’s disease, inflammation, metabolism, neurodegenerative, obesity, quality of life Background: Obesity has emerged as a major global public health concern and has been increasingly implicated as a modifiable risk factor for neurodegenerative diseases, including Alzheimer’s disease (AD). While numerous epidemiological and experimental studies have examined the association between excess adiposity and cognitive decline, findings remain heterogeneous, particularly with respect to the timing of obesity exposure across the lifespan. Objective: This systematic review aimed to synthesize current evidence on the relationship between obesity and Alzheimer’s disease, focusing on epidemiological associations, underlying biological mechanisms, and the influence of life-course timing on disease risk. Methods: A structured literature search was conducted in major electronic databases, including Google Scholar, PubMed, and Scopus, to identify peer-reviewed articles examining the association between obesity and Alzheimer’s disease. Observational cohort studies, case-control studies, neuroimaging investigations, and mechanistic experimental studies published in English were considered. Eligible studies were screened according to predefined inclusion and exclusion criteria. Data were extracted and qualitatively synthesized to evaluate patterns of association, proposed mechanisms, and methodological considerations. Results: The evidence consistently demonstrates that midlife obesity is associated with an increased risk of later-life Alzheimer’s disease and cognitive decline. Central adiposity and metabolic syndrome components showed stronger associations with AD risk than body mass index (BMI) alone. Mechanistic studies suggest that obesity contributes to AD pathogenesis through chronic systemic inflammation, insulin resistance, oxidative stress, cerebrovascular dysfunction, and impaired brain glucose metabolism. Neuroimaging findings indicate structural and functional alterations in obesity that overlap with AD-vulnerable brain regions. In contrast, late-life obesity demonstrated inconsistent associations, likely influenced by reverse causation and disease-related weight loss. Conclusion: The findings support the hypothesis that obesity – particularly during midlife – acts as a significant and potentially modifiable risk factor for Alzheimer’s disease. The relationship appears to be mediated by complex metabolic and inflammatory pathways. Preventive strategies targeting obesity and metabolic dysfunction across the lifespan may contribute to reducing the future burden of Alzheimer’s disease. Further longitudinal and biomarker-integrated studies are required to clarify causal mechanisms and inform targeted interventions.
Kurzfassung: Hintergrund: Adipositas hat sich zu einem bedeutenden globalen Problem der öffentlichen Gesundheit entwickelt und wird zunehmend als beeinflussbarer Risikofaktor für neurodegenerative Erkrankungen, einschließlich der Alzheimer-Krankheit (AD), diskutiert. Zwar haben zahlreiche epidemiologische und experimentelle Studien den Zusammenhang zwischen starkem Übergewicht und kognitivem Abbau untersucht, doch sind die Ergebnisse uneinheitlich – insbesondere im Hinblick auf den Zeitpunkt des Auftretens von Adipositas im Laufe des Lebens. |
